Extremity Care

Extremity Care develops and distributes advanced cell and tissue technologies for wound care, including placental tissue allografts, xenografts and acellular dermis products. A subsidiary of Tiger BioSciences, the company serves physician clinics and other healthcare providers across the wound care, regenerative medicine and durable medical equipment (DME) sectors. Its stated emphasis is on regulatory compliance and quality standards, with a commitment to best-in-class compliance across its business operations and to supporting physician clinics throughout the patient care journey.

The product portfolio is led by carePATCH™, a dual-layer amniotic membrane used as a protective barrier for acute and chronic wounds. Placental tissue solutions for wound care are marketed under the names CompleteFT™, Restorigin™ and barrera™. The company also supplies carePAC, personalised convenience kits designed to support patient compliance and outcomes.

Extremity Care has been an accredited DME vendor with Medicare since 2018. Further details on founding date, team size and funding are not published. More information is available at extremitycare.com.